Screener
Medtronic MDT Research and development expense
Research and development expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions, except per share data) | Fiscal Year / 2026 | Fiscal Year / 2025 | Fiscal Year / 2024 |
|---|---|---|---|
| Net sales | $36,364 | $33,537 | $32,364 |
| Costs and expenses: | |||
| Cost of products sold, excluding amortization of intangible assets | 12,721 | 11,632 | 11,216 |
| Research and development expense | 2,873 | 2,732 | 2,735 |
| Selling, general, and administrative expense | 11,784 | 10,849 | 10,736 |
| Amortization of intangible assets | 1,772 | 1,807 | 1,693 |
| Restructuring charges, net | 249 | 267 | 226 |
| Certain litigation charges, net | 113 | 317 | 149 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's research and development expense?
- Medtronic (MDT) reported research and development expense of $671M in Q1 2026.
- How has Medtronic's research and development expense changed year-over-year?
- Medtronic's research and development expense decreased by 1.9% year-over-year, from $684M to $671M.
- What is the long-term trend for Medtronic's research and development expense?
- Over 4 years (2022 to 2026), Medtronic's research and development expense has grown at a 1.1% compound annual growth rate (CAGR), from $2.75B to $2.87B.
Ask your AI about Medtronic's research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude